Compare MTX & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | INSP |
|---|---|---|
| Founded | 1968 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2004 | 2018 |
| Metric | MTX | INSP |
|---|---|---|
| Price | $62.36 | $70.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 18 |
| Target Price | ★ $91.25 | $68.00 |
| AVG Volume (30 Days) | 137.7K | ★ 736.2K |
| Earning Date | 10-29-2026 | 11-02-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,072,600,000.00 | $82,050,000.00 |
| Revenue This Year | $5.23 | N/A |
| Revenue Next Year | $4.70 | $3.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $53.94 | $38.91 |
| 52 Week High | $84.34 | $147.03 |
| Indicator | MTX | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 30.32 | 52.71 |
| Support Level | N/A | $67.10 |
| Resistance Level | $70.21 | $75.31 |
| Average True Range (ATR) | 1.19 | 2.96 |
| MACD | -0.07 | -0.38 |
| Stochastic Oscillator | 3.72 | 41.15 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.